123I-PE2I

N/A

Report date: 2025/11/24 11:49:10
NME

Base Information

Drug Name123I-PE2I
Drug Alias Nameiodine-123-labeled dopamine antagonistiodine-123-PE2IPE2I-[123I]123I-PE2I
ClassificationSmall moleculesDiagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agent +[5] 
Mechanisms of ActionDopamine transporter antagonists
TargetsDopamine transporter
Therapy Area/IndicationsNerve DegenerationParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of CopenhagenRigshospitaletBispebjerg Hospital
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of CopenhagenRigshospitaletBispebjerg Hospital
Active IndicationsN/A
Inactive IndicationsNerve DegenerationParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A